Stem cell project to cure AMD underway

Article

Researchers from University College London (UCL), Moorfields Eye Hospital and the University of Sheffield, UK are launching a pioneering project that plans to use stem cells to cure blindness resulting from age-related macular degeneration.

Researchers from University College London (UCL), Moorfields Eye Hospital and the University of Sheffield, UK are launching a pioneering project that plans to use stem cells to cure blindness resulting from age-related macular degeneration (AMD).

The procedure will generate replacement retinal pigment epithelial (RPE) cells from stem cells in the laboratory. Surgeons will then inject a small patch of new cells, measuring 4 x 6 mm, back into the eye.

An anonymous US donor, frustrated by the US curb on stem cell research, has made the project possible by donating £4 million. The researchers hope that, if successful, the operation could become as routine as cataract surgery.

It is hoped that the first test patients will receive the treatment in just five years time.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.